Janux Therapeutics (JANX) Stock Chart & Stock Price History $27.12 +1.39 (+5.38%) As of 01:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Janux Therapeutics Stock Price Performance The Janux Therapeutics (JANX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 48.59%, with a year-to-date return of -49.36%. In the past month, the stock has increased 15.09%, reflecting recent market activity. As of the latest close, Janux Therapeutics traded at $25.73 with a market cap of $1.55 billion and volume of 712,132 shares. Receive JANX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Janux Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.28%1 Month Performance+15.09%3 Month Performance+5.26%Year-To-Date Performance-49.36%1 Year Performance-48.59% JANX Stock Chart for Wednesday, October, 15, 2025 JANX Chart by TradingView Janux Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/14/2025$26.29$25.73-2.13%$26.22$25.26712,132 shs$1.55 billion10/13/2025$26.51$26.29-0.83%$26.63$25.181.12 million shs$1.58 billion10/10/2025$25.85$26.51+2.55%$26.73$25.351.01 million shs$1.59 billion10/09/2025$24.20$25.85+6.82%$26.05$23.951.69 million shs$1.55 billion10/08/2025$22.69$24.20+6.65%$24.24$22.601.05 million shs$1.45 billion10/07/2025$22.76$22.69-0.31%$23.30$22.23931,142 shs$1.36 billion10/06/2025$24.00$22.76-5.17%$24.49$22.70923,265 shs$1.37 billion10/03/2025$23.31$24.00+2.96%$24.59$23.32824,135 shs$1.44 billion10/02/2025$23.70$23.31-1.65%$24.45$23.00676,069 shs$1.40 billion10/01/2025$24.44$23.70-3.03%$25.35$23.53813,833 shs$1.42 billion Get the Latest News and Ratings for JANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Janux Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/30/2025$23.70$24.44+3.12%$24.68$22.921.01 million shs$1.47 billion09/29/2025$23.23$23.70+2.02%$23.90$23.07727,410 shs$1.42 billion09/26/2025$21.77$23.23+6.71%$23.29$21.83748,575 shs$1.40 billion09/25/2025$22.84$21.77-4.68%$22.86$21.73643,851 shs$1.31 billion09/24/2025$22.98$22.84-0.61%$23.70$22.80837,690 shs$1.37 billion09/23/2025$23.51$22.98-2.25%$23.75$22.79460,864 shs$1.38 billion09/22/2025$23.45$23.51+0.26%$23.80$22.69503,278 shs$1.41 billion09/19/2025$24.40$23.45-3.89%$24.54$23.402.36 million shs$1.41 billion09/18/2025$23.46$24.40+4.01%$24.50$23.85680,973 shs$1.47 billion09/17/2025$23.41$23.46+0.21%$24.79$23.38538,344 shs$1.41 billion09/16/2025$23.56$23.41-0.64%$24.08$23.15570,771 shs$1.41 billion09/15/2025$24.05$23.56-2.04%$24.23$23.32553,130 shs$1.42 billion Related Companies PCVX Stock Chart MTSR Stock Chart KRYS Stock Chart PTCT Stock Chart ARWR Stock Chart ACLX Stock Chart KYMR Stock Chart PTGX Stock Chart CRNX Stock Chart ZLAB Stock Chart Receive JANX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Janux Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:JANX) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Janux Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Janux Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
